Share This Article:

Evaluation of Myocardial Performance in Hypertensive Patients with Type 2 Diabetes and Normal Ejection Fraction

Abstract Full-Text HTML XML Download Download as PDF (Size:271KB) PP. 1721-1724
DOI: 10.4236/health.2015.712187    2,350 Downloads   2,706 Views  

ABSTRACT

Diabetes (DM) and hypertension (HT) cause changes in cardiac performance. Long-term diabetes and hypertension can lead to changes in cardiac contractility, reduced left ventricular efficiency and heart failure. The aim of this study is to evaluate the effect of the coexistence of diabetes mellitus and hypertension on left ventricular myocardial performance and structural changes. The study involved 45 patients with essential hypertension and type 2 diabetes (14 males and 31 females, their mean age was 53.28 ± 13.28 years), and 45 healthy subjects (10 males and 35 females, their mean age was 48.11 ± 13.07 years) as a control group. Transthoracic echocardiography was done for all patients. The echocardiographic measurements included: left ventricle internal diameter at end diastole (LVIDd), left ventricle internal diameter at end systole (LVIDs), peak velocity of early transmitral flow (E), peak velocity of late transmitral flow (A), ejection fraction (EF%), isovolumic relaxation time (IVRT), isovolumic contraction time (IVCT) and ejection time (ET) from which the index of myocardial performance (IMP) was calculated. Results revealed a significant change in the ratio (E/A) between patients and controls (-32.45%) with p value < 0.05, and the change in (LVIDd) and (LVIDs) between patients and control groups were (4.61%) and (0.754%) respectively with insignificant p value. The change in IMP was (44.65%), with p value < 0.05, and the change in ejection fraction (EF%) was (-1.49) with p value > 0.05. In conclusion, diabetic patients with hypertension had an increase in IMP and reduced E/A indicating deterioration in cardiac performance despite normal ejection fraction and insignificant change in LV dimensions.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Hussein, M. , Essa, S. and Saleh, A. (2015) Evaluation of Myocardial Performance in Hypertensive Patients with Type 2 Diabetes and Normal Ejection Fraction. Health, 7, 1721-1724. doi: 10.4236/health.2015.712187.

References

[1] Wachter, R., Lüers, C., Kleta, S., Griebel, K., Herrmann-Lingen, C., et al. (2007) Impact of Diabetes on Left Ventricular Diastolic Function in Patients with Arterial Hypertension. European Journal of Heart Failure, 9, 469-476.
http://dx.doi.org/10.1016/j.ejheart.2007.01.001
[2] Andersen, N.H., Poulsen, S.H., Helleberg, K., Ivarsen, P., Knudsen, S.T. and Mogensen, C.E. (2003) Impact of Essential Hypertension and Diabetes Mellitus on Left Ventricular Systolic and Diastolic Performance. European Journal of Echocardiography, 4, 306-312.
http://dx.doi.org/10.1016/S1525-2167(03)00034-9
[3] Fang, Z.Y., Schull-Meade, R., Leano, R., Mottram, P.M., Prins, J.B. and Marwick, T.H. (2005) Screening for Heart Disease in Diabetic Subjects. American Heart Journal, 149, 349-354.
http://dx.doi.org/10.1016/j.ahj.2004.06.021
[4] Levy, D., Larson, M.G., Vasan, R.S., Kannel, W.B. and Ho, K.K. (1996) The Progression from Hypertension to Congestive Heart Failure. Journal of the American Medical Association, 275, 1557-1562.
http://dx.doi.org/10.1001/jama.1996.03530440037034
[5] Cohen, G.I., Pietrolungo, J.F., Thomas, J.D. and Klein, A.L. (1996) A Practical Guide to Assessment of Ventricular Diastolic Function Using Doppler Echocardiography. Journal of the American College of Cardiology, 27, 1753-1760.
http://dx.doi.org/10.1016/0735-1097(96)00088-5
[6] Nagueh, S.F., Middleton, K.J., Kopelen, H.A., Zoghbi, W.A. and Quinnones, M.A. ( 1997) Doppler Tissue Imaging: A Noninvasive Technique for Evaluation of Left Ventricular Relaxation and Estimation of Filling Pressures, JACC, 30, 1527-1533.
http://dx.doi.org/10.1016/S0735-1097(97)00344-6
[7] Tei, C. (1995) New Non-Invasive Index for Combined Systolic and Diastolic Ventricular Function. Journal of Cardiology, 26, 135-136.
[8] Movesian, M.A. and Schwinger, R.H. (1998) Calcium Sequestration by the Sarcoplasmic Reticulum in Heart Failure. Cardiovascular Research, 37, 352-359.
http://dx.doi.org/10.1016/S0008-6363(97)00259-9
[9] Martín-Timón, I., Sevillano-Collantes, C., Segura-Galindo, A. and del Canizo-Gómez, F.J. (2014) Type 2 Diabetes and Cardiovascular Disease: Have All Risk Factors the Same Strength? World Journal of Diabetes, 5, 444-470.
[10] Echouffo-Tcheugui, J.B. and Kengne, A.P. (2013) On the Importance of Global Cardiovascular Risk Assessment in People with Type 2 Diabetes. Primary Care Diabetes, 7, 95-102.
http://dx.doi.org/10.1016/j.pcd.2013.03.002
[11] Factor, S.M., Minase, T. and Sonnenblick, E.H. (1980) Clinical and Morphological Features of Human Diabetic Cardiomyopathy. American Heart Journal, 99,446-458.
http://dx.doi.org/10.1016/0002-8703(80)90379-8
[12] Liu, J.E., Palmieri, V., Roman, M.J., Bella, J.N., et al. (2001) The Impact of Diabetes on Left Ventricular Filling Pattern in Normotensive and Hypertensive Adults: The Strong Heart Study. JACC, 37, 1943-1949.
http://dx.doi.org/10.1016/S0735-1097(01)01230-X
[13] van Hoeven, K.H. and Factor, S.M. (1990) A Comparison of the Pathological Spectrum of Hypertensive, Diabetic, and Hypertensive-Diabetic Heart Disease. Circulation, 82, 848-855.
http://dx.doi.org/10.1161/01.CIR.82.3.848

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.